Ingemar Lagerlöf

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Ejection Fraction

Hodgkin Lymphoma

Radiation Therapy

Top Venues

British journal of haematology

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Ingemar Lagerlöf, Helena Fohlin, Gunilla Enblad, Bengt Glimelius, Christina Goldkuhl, Marzia Palma, Lisa Åkesson, Ingrid Glimelius, Daniel Molin
Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (13) (2022)
Karin Fjordén, Sara Ekberg, Nevzeta Kuric, Karin E Smedby, Ingemar Lagerlöf, Thomas S Larsen, Judit M Jørgensen, Peter de Nully Brown, Mats Jerkeman
Idelalisib in relapsed/refractory diffuse large B-cell lymphoma: results from a Nordic Lymphoma Group phase II trial. British journal of haematology (2021)
Lasse Hjort Kyneb Jakobsen, Fredrik Ellin, Knut B Smeland, Tove Wästerlid, Jacob H Christensen, Judit M Jørgensen, Pär L Josefsson, Andreas K Øvlisen, Harald Holte, Yngvild N Blaker, Jacob H Grauslund, Jon Bjørn, Daniel Molin, Ingemar Lagerlöf, Karin E Smedby, Katherine Colvin, Gita Thanarajasingam, Matthew J Maurer, Thomas M Habermann, Kevin W Song, Katie Y Zhu, Alina S Gerrie, Chan Y Cheah, Tarec C El-Galaly
Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real-world patients. British journal of haematology 189 (4) (2020)
Ingemar Lagerlöf, Harald Holte, Ingrid Glimelius, Magnus Björkholm, Gunilla Enblad, Martin Erlanson, Øystein Fluge, Helena Fohlin, Alexander Fosså, Christina Goldkuhl, Anita Gustavsson, Ann-Sofie Johansson, Johan Linderoth, Ole Nome, Marzia Palma, Lisa Åkesson, Bjørn Østenstad, Cecilia Raud, Bengt Glimelius, Daniel Molin
No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy. British journal of haematology 188 (5) (2019)